LabPulse.com

Lab News

Lucid Diagnostics files for IPO on Nasdaq exchange
September 23, 2021 -- Lucid Diagnostics has filed for an initial public offering (IPO), and the company's shares will be traded on the Nasdaq stock exchange under the symbol "LUCD." Read More

Emerson launches new Wellevate clinical lab service
September 23, 2021 -- Emerson Ecologics has launched a new virtual hub called Wellevate Labs, where integrative health professionals can order, review, and share lab results. Read More

PathAI, Summit Clinical partner for NASH trial services
September 22, 2021 -- PathAI recently entered a partnership with Summit Clinical Research that will launch a clinical trial services solution for developers of drugs to treat nonalcoholic steatohepatitis (NASH). Read More

FDA clears 1st prostate pathology AI software application
September 21, 2021 -- The U.S. Food and Drug Administration (FDA) has authorized marketing of Paige.ai's Paige Prostate artificial intelligence (AI) software, the first prostate pathology AI application to receive regulatory clearance in the U.S. Read More

Lab owner, woman charged in Medicare kickback scheme
September 21, 2021 -- An owner of a Louisiana clinical laboratory and a Florida woman have been charged in a scheme to pay and receive kickbacks for Medicare diagnostic services for urine drug testing. Read More

ASCP adds hybrid option to October conference
September 21, 2021 -- The American Society for Clinical Pathology (ASCP) has added a hybrid option to its annual conference scheduled to take place in Boston October 27-29, as many medical conferences see lower in-person attendance due to concerns about COVID-19. Read More

MiR Scientific touts data on prostate cancer liquid biopsy
September 20, 2021 -- MiR Scientific is highlighting results presented at the American Urological Association annual meeting that found that its miR Sentinel prostate cancer liquid biopsy test was able to detect and risk-classify prostate cancer at the molecular level with accuracy of more than 90%. Read More

DocGo deploys no-cost testing program
September 20, 2021 -- Mobile health services provider DocGo has deployed a no-cost, multiplex co-testing program that includes rapid antigen tests for influenza A and B. Read More

Thermo Fisher gets FDA approval for lung cancer test
September 17, 2021 -- Thermo Fisher Scientific's Oncomine Dx Target Test for use as a companion diagnostic in patients with non-small cell lung cancer recently received approval from the U.S. Food and Drug Administration (FDA), the company announced. Read More

FDA issues alerts for Abbott Molecular COVID-19 testing kits
September 17, 2021 -- The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and healthcare providers of the potential for false-positive results for testing kits for COVID-19 from Abbott Molecular. Read More

1 2 3…166 next »

Webinars/Videos